Besides, we also found that when combined with R-CHOP, QHF can significantly lower the overall side effect frequencies and improve the short-term effects of R-CHOP in treating initial onset DLBCL patients [24]. Here, DDIT3 is linked to diffuse large B-cell lymphoma.